Position in DNLI
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$629,265
+$96,715 QoQ
Shares Held
24,466
-11.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#143
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. DNLI ranks #43 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $629,265 | 24,466 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $532,550 | 27,737 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $506,559 | 30,682 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $404,454 | 27,855 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $455,822 | 32,582 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $454,902 | 33,461 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $852,393 | 41,825 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $930,645 | 31,948 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $575,809 | 24,798 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $640,326 | 31,205 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $609,142 | 28,385 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $501,969 | 24,332 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $714,820 | 24,223 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $513,469 | 22,286 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $748,311 | 26,908 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $699,394 | 22,789 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $652,580 | 22,174 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,025,611 | 31,881 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,757,329 | 39,402 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,009,776 | 39,837 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,558,195 | 45,362 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,917,246 | 33,577 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,717,006 | 32,438 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $888,118 | 24,787 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $614,752 | 25,424 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $285,045 | 16,279 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||